<DOC>
	<DOCNO>NCT02960919</DOCNO>
	<brief_summary>This prospective observational study assess clinical outcome child 2 59 month age pneumonia co-morbidities present tertiary hospital outpatient set Malawi , Africa risk mortality complication thus , typically exclude childhood pneumonia study .</brief_summary>
	<brief_title>Innovative Treatments Pneumonia ( ITIP ) 3</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Male female , 2 59 month age . Excluded enrollment Innovative Treatment Pneumonia ( ITIP ) 1 ITIP2 clinical trial due presence following : Hypoxia ( SaO2 &lt; 90 % room air , assess pulse oximeter ) . Severe respiratory distress ( e.g. , presence grunting , nasal flaring , head nodding , severe chestindrawing ) . Severe malaria , classify World Health Organization ( WHO ) guideline hospital care child , include positive malaria rapid antibody test result . Severe anemia , classify WHO Integrated Management Childhood Illness ( IMCI ) guideline ( i.e. , severe palmar pallor ) positive malaria rapid antibody test result . severe acute malnutrition ( SAM ) ( i.e. , weight height/length &lt; 3 SD , midupper arm circumference ( MUAC ) &lt; 115 , edema ) . HIV1 seropositivity HIV1 exposure , assess follow : An HIVpositive result upon rapid antibody test . If child le 24 month age HIVnegative result upon rapid antibody test document past three month , child 's biological mother 's HIV status need assess . If mother HIVpositive , child include . If mother documentation HIVnegative test result past 3 month , test via rapid antibody test determine child 's eligibility study . Ability willingness child 's caregiver provide inform consent available followup ( inpatient ward , return KCH schedule study followup visit , phone ) plan duration study . Possible tuberculosis ( cough 14 day ) . Stridor calm . Severe anemia , classify WHO IMCI guideline ( i.e. , severe palmar pallor ) negative malaria rapid antibody test result . Known allergy penicillin amoxicillin . Receipt antibiotic treatment 48 hour prior study base caregiver 's selfreport and/or documentation child 's medical record . Living outside Lilongwe urban area , study catchment area . Any medical psychosocial condition circumstance , opinion investigator , would interfere conduct study study participation might jeopardize child 's health . Participation clinical study investigational product within 12 week prior enrollment plan begin participation study . Prior participation ITIP1 , ITIP2 ITIP3 previous pneumonia diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>